Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-19 Purchase | 2026-05-21 07:00 am | RenovoRx Inc. | RNXT | VOLL MARK Chief Financial Officer | 25,000 | $0.7876 | $19,690 | 239,580 (Indirect Direct) | View |
| 2026-03-20 Purchase | 2026-03-24 9:16 pm | RenovoRx Inc. | RNXT | Marton Laurence Director | 9,720 | $0 | $0 | 14,580 (Indirect) | View |
| 2026-03-20 Purchase | 2026-03-24 9:16 pm | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 24,300 | $0 | $0 | 376,490 (Indirect Direct) | View |
| 2026-03-20 Purchase | 2026-03-24 9:15 pm | RenovoRx Inc. | RNXT | VOLL MARK Chief Financial Officer | 97,200 | $0 | $0 | 145,800 (Indirect) | View |
| 2026-01-21 Purchase | 2026-01-22 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 10,000 | $0.9975 | $9,975 | 798,460 (Direct) | View |
| 2025-12-31 Purchase | 2026-01-05 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 9,795 | $0.86 | $8,424 | 788,460 (Direct) | View |
| 2025-12-30 Purchase | 2026-01-02 5:00 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 205 | $0.826 | $169 | 778,665 (Direct) | View |
| 2025-12-18 Purchase | 2025-12-22 07:00 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 5,000 | $0.9013 | $4,507 | 340,040 (Direct) | View |
| 2025-12-17 Purchase | 2025-12-19 07:00 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 5,000 | $0.8524 | $4,262 | 335,040 (Direct) | View |
| 2025-12-16 Purchase | 2025-12-17 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 12,000 | $0.85 | $10,200 | 778,460 (Direct) | View |
| 2025-12-05 Purchase | 2025-12-08 07:00 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 10,000 | $0.96 | $9,600 | 766,460 (Direct) | View |
| 2025-11-21 Purchase | 2025-11-24 6:00 pm | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 22,000 | $0.8 | $17,600 | 756,460 (Direct) | View |
| 2025-08-22 Purchase | 2025-08-26 06:10 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 10,000 | $0.92965 | $9,297 | 330,040 (Direct) | View |
| 2025-06-05 Purchase | 2025-06-09 06:03 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 21,000 | $1.4 | $29,400 | 734,460 (Direct) | View |
| 2025-04-15 Purchase | 2025-04-17 06:10 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 15,000 | $0.9 | $13,500 | 1,113,460 (Direct) | View |
| 2025-04-15 Purchase | 2025-04-16 06:08 am | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 7,500 | $0.9095 | $6,821 | 320,040 (Direct) | View |
| 2025-04-11 Purchase | 2025-04-14 06:30 am | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 20,000 | $0.8 | $16,000 | 1,098,460 (Direct) | View |
| 2025-04-08 Purchase | 2025-04-10 7:02 pm | RenovoRx Inc. | RNXT | Kocak Ron VP Controller and PAO | 12,595 | $0.79484 | $10,011 | 12,595 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-04-22 Other | 2026-06-24 5:20 pm | N/A N/A | RenovoRx Inc. | RNXT | RYAN UNA S Director | 26,838 | $0.9315 | 194,330 (Indirect) | View |
| 2022-04-22 Other | 2026-06-24 5:20 pm | N/A N/A | RenovoRx Inc. | RNXT | RYAN UNA S Director | 16,206 | $1.6215 | 194,330 (Indirect) | View |
| 2022-03-03 Other | 2026-06-24 5:20 pm | N/A N/A | RenovoRx Inc. | RNXT | RYAN UNA S Director | 6,332 | $3.95 | 194,330 (Indirect) | View |
| 2022-03-03 Other | 2026-06-24 5:20 pm | N/A N/A | RenovoRx Inc. | RNXT | RYAN UNA S Director | 47,789 | $4.19 | 194,330 (Indirect) | View |
| 2026-04-03 Option Award | 2026-04-07 8:00 pm | N/A N/A | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 946,107 | $0 | 946,107 (Direct) | View |
| 2026-04-03 Option Award | 2026-04-07 8:00 pm | N/A N/A | RenovoRx Inc. | RNXT | VOLL MARK Chief Financial Officer | 80,000 | $0 | 214,580 (Direct) | View |
| 2026-04-03 Option Award | 2026-04-07 8:00 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 128,550 | $0 | 128,550 (Direct) | View |
| 2026-04-03 Option Award | 2026-04-07 8:00 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 621,727 | $0 | 621,727 (Direct) | View |
| 2026-03-25 Option Award | 2026-03-27 07:32 am | N/A N/A | RenovoRx Inc. | RNXT | VOLL MARK Chief Financial Officer | 12,380 | $0 | 134,580 (Direct) | View |
Ownership(A) | 2026-03-27 07:30 am | N/A N/A | RenovoRx Inc. | RNXT | VOLL MARK Chief Financial Officer | 0 | $0 | 25,000 (Direct) | View |
Ownership | 2026-03-24 9:00 pm | N/A N/A | RenovoRx Inc. | RNXT | VOLL MARK Chief Financial Officer | 0 | $0 | 25,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-03 09:19 am | N/A 2035-10-01 | RenovoRx Inc. | RNXT | Marton Laurence Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 8:23 pm | N/A 2035-10-01 | RenovoRx Inc. | RNXT | Macfarlane K. Angela Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 8:17 pm | N/A 2035-10-01 | RenovoRx Inc. | RNXT | RYAN UNA S Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 8:10 pm | N/A 2035-10-01 | RenovoRx Inc. | RNXT | Spiegel Robert J. Director | 47,640 | $0 | 47,640 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 63,636 | $0 | 63,636 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 102,498 | $0 | 102,498 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 6,619 | $0 | 6,619 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 4:45 pm | N/A N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 41,600 | $0 | 41,600 (Direct) | View |
| 2025-04-22 Gift | 2025-06-06 5:15 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 400,000 | $0 | 713,460 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-06 4:10 pm | N/A N/A | RenovoRx Inc. | RNXT | Marton Laurence Director | 20,480 | $0.15 | 66,164 (Direct) | View |
| 2025-05-02 Exercise | 2025-05-06 4:10 pm | N/A 2025-10-14 | RenovoRx Inc. | RNXT | Marton Laurence Director | 20,480 | $0 | 66,164 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Bagai Shaun Chief Executive Officer | 409,992 | $0 | 409,992 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Gentry Leesa Chief Clinical Officer | 26,477 | $0 | 26,477 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Kocak Ron VP, Controller and PAO | 166,400 | $0 | 166,400 (Direct) | View |
| 2025-04-14 Option Award | 2025-04-16 5:18 pm | N/A N/A | RenovoRx Inc. | RNXT | Agah Ramtin Chief Medical Officer | 254,542 | $0 | 254,542 (Direct) | View |